| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.086 | 28.954 | 31.881 | 44.485 | 46.801 | 48.188 | 70.247 | 81.866 | 91.823 | 97.112 |
| Total Income - EUR | 26.093 | 28.956 | 31.881 | 44.485 | 46.801 | 48.190 | 70.250 | 81.868 | 91.825 | 97.116 |
| Total Expenses - EUR | 21.428 | 18.222 | 22.070 | 25.437 | 24.437 | 24.543 | 28.411 | 33.137 | 46.582 | 50.021 |
| Gross Profit/Loss - EUR | 4.665 | 10.734 | 9.810 | 19.048 | 22.364 | 23.647 | 41.839 | 48.731 | 45.244 | 47.095 |
| Net Profit/Loss - EUR | 3.882 | 10.444 | 9.492 | 18.604 | 21.896 | 23.202 | 41.137 | 47.966 | 44.463 | 44.240 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Endomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.242 | 4.933 | 22.544 | 18.373 | 14.559 | 29.823 | 31.371 | 23.375 | 15.294 | 7.566 |
| Current Assets | 14.137 | 7.843 | 4.912 | 27.861 | 29.503 | 11.388 | 27.485 | 43.299 | 80.826 | 110.741 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 2.185 | 0 | 752 | 17.328 | 1.356 | 3.422 | 760 | 1.315 | 0 |
| Cash | 14.137 | 5.658 | 4.912 | 27.109 | 12.175 | 10.032 | 24.063 | 42.539 | 79.511 | 110.741 |
| Shareholders Funds | 17.520 | 10.489 | 19.803 | 38.043 | 21.938 | 27.725 | 49.714 | 47.028 | 91.348 | 44.280 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.859 | 2.287 | 7.653 | 8.191 | 22.124 | 13.486 | 9.142 | 19.647 | 4.772 | 74.028 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomedica Srl